Comparative injection-site pain and tolerability of subcutaneous serum-free formulation of interferonβ-1a versus subcutaneous interferonβ-1b: results of the randomized, multicenter, Phase IIIb REFORMS study
© Singer et al.; licensee BioMed Central Ltd. 2012
Received: 2 July 2012
Accepted: 21 November 2012
Published: 6 December 2012
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|2 Jul 2012||Submitted||Original manuscript|
|16 Jul 2012||Reviewed||Reviewer Report - Francesco Patti|
|24 Jul 2012||Reviewed||Reviewer Report - Gabriel Pardo|
|9 Aug 2012||Reviewed||Reviewer Report - Sybil Wray|
|31 Oct 2012||Author responded||Author comments - Barry Singer|
|Resubmission - Version 2|
|31 Oct 2012||Submitted||Manuscript version 2|
|Resubmission - Version 3|
|Submitted||Manuscript version 3|
|20 Nov 2012||Reviewed||Reviewer Report - Gabriel Pardo|
|20 Nov 2012||Reviewed||Reviewer Report - Sybil Wray|
|Resubmission - Version 4|
|Submitted||Manuscript version 4|
|21 Nov 2012||Editorially accepted|
|6 Dec 2012||Article published||10.1186/1471-2377-12-154|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.